Özal, Tuğba Arzu

Profile Picture
Name Variants
Özal, Tuğba Arzu
T.,Özal
T. A. Özal
Tuğba Arzu, Özal
Ozal, Tugba Arzu
T.,Ozal
T. A. Ozal
Tugba Arzu, Ozal
Ildeniz, A. Tugba Ozal
Job Title
Öğr. Gör. Dr.
Email Address
Tugba.ozal@khas.edu.tr
Main Affiliation
Business Administration
Status
Former Staff
Website
ORCID ID
Scopus Author ID
Turkish CoHE Profile ID
Google Scholar ID
WoS Researcher ID

Sustainable Development Goals Report Points

SDG data could not be loaded because of an error. Please refresh the page or try again later.
Scholarly Output

4

Articles

1

Citation Count

0

Supervised Theses

3

Filters

20141
Reset filters

Settings

Subject: hERG ion channel

Scholarly Output Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    Article
    Citation - WoS: 5
    Citation - Scopus: 5
    Designing of Multi-Targeted Molecules Using Combination of Molecular Screening and in Silico Drug Cardiotoxicity Prediction Approaches
    (Elsevier Science Inc, 2014) Buturak, Birce; Özal, Tuğba Arzu; Durdagi, Serdar; Noskov, Sergei Y.; Ildeniz, A. Tugba Ozal; Business Administration
    We have previously investigated and reported a set of phenol- and indole-based derivatives at the binding pockets of carbonic anhydrase isoenzymes using in silico and in vitro analyses. In this study we extended our analysis to explore multi-targeted molecules from this set of compounds. Thus 26 ligands are screened at the binding sites of 229 proteins from 5 main enzyme family classes using molecular docking algorithms. Derived docking scores are compared with reported results of ligands at carbonic anhydrase I and II isoenzymes. Results showed potency of multi-targeted drugs of a few compounds from investigated ligand set. These promising ligands are then tested in silico for their cardiotoxicity risks. Results of this work can be used to improve the desired effects of these compounds by molecular engineering studies. In addition these results may lead to further investigation of studied molecules by medicinal chemists to explore different therapeutic aims. (C) 2014 Elsevier Inc. All rights reserved.